Lonza Will Expand Viral Vaccines Unit | May 23, 2011 Issue - Vol. 89 Issue 21 | Chemical & Engineering News
Volume 89 Issue 21 | p. 22 | Concentrates
Issue Date: May 23, 2011

Lonza Will Expand Viral Vaccines Unit

Department: Business
Keywords: viral vaccines, gene therapy

Lonza will expand its viral-based therapeutics business with the construction of a clean room at its Houston facility. To open early next year, the clean room will house disposable bioreactors of up to 2,000 L that support late-stage viral vaccine and gene therapy projects. Lonza entered viral manufacturing in August 2010 through the acquisition of Houston-based Vivante GMP Solutions. The Swiss firm says viral vaccines are cheaper to make than traditional egg-based vaccines.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment